chr5-69419673-C-A
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The ENST00000325631.10(MARVELD2):c.288C>A(p.Asp96Glu) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000533 in 1,614,160 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 14/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★★).
Frequency
Consequence
ENST00000325631.10 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
MARVELD2 | NM_001038603.3 | c.288C>A | p.Asp96Glu | missense_variant | 2/7 | ENST00000325631.10 | NP_001033692.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
MARVELD2 | ENST00000325631.10 | c.288C>A | p.Asp96Glu | missense_variant | 2/7 | 1 | NM_001038603.3 | ENSP00000323264 | P1 |
Frequencies
GnomAD3 genomes AF: 0.0000854 AC: 13AN: 152174Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.0000639 AC: 16AN: 250410Hom.: 0 AF XY: 0.0000664 AC XY: 9AN XY: 135592
GnomAD4 exome AF: 0.0000499 AC: 73AN: 1461868Hom.: 0 Cov.: 35 AF XY: 0.0000523 AC XY: 38AN XY: 727238
GnomAD4 genome AF: 0.0000854 AC: 13AN: 152292Hom.: 0 Cov.: 32 AF XY: 0.0000806 AC XY: 6AN XY: 74472
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine | Oct 07, 2014 | Variant classified as Uncertain Significance - Favor Benign. The p.Asp96Glu vari ant in MARVELD2 has not been previously reported in individuals with hearing los s, but has been identified in 1/4406 African American chromosomes by the NHLBI E xome Sequencing Project (http://evs.gs.washington.edu/EVS/; dbSNP rs73113102). A lthough this variant has been seen in the general population, its frequency is n ot high enough to rule out a pathogenic role, particularly for a recessive disor der. Aspartic acid (Asp) at position 96 is not conserved in mammals or evolution ary distant species, and at least two mammals (greater Egyptian jerboa and rabbi t) carry a glutamic acid (Glu) at this position, raising the possibility that th is change may be tolerated. Additional computational prediction tools suggest th at the p.Asp96Glu variant may not impact the protein, though this information is not predictive enough to rule out pathogenicity. In summary, while the clinical significance of the p.Asp96Glu variant is uncertain, these data suggest that it is more likely to be benign. - |
not provided Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | GeneDx | Dec 22, 2021 | In silico analysis, which includes protein predictors and evolutionary conservation, supports that this variant does not alter protein structure/function; Has not been previously published as pathogenic or benign to our knowledge - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at